Cy5-αCD20

Cy5-αCD20: sourced facts only. name: "a fluorescently labeled mouse anti-CD20 B cell depleting antibody (Cy5-αCD20)" [PMID:36945772]; target: "a fluorescently labeled mouse anti-CD20 B cell depleting antibody (Cy5-αCD20)" [PMID:36945772]; developer: "Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, 399 Royal Parade, Parkville, Victoria 3052, Australia." [PMID:36945772]; modality: "a fluorescently labeled mouse anti-CD20 B cell depleting antibody (Cy5-αCD20)" [PMID:36945772]; stage: "We, therefore, assessed the lymph node distribution, absorption and plasma pharmacokinetics, and B cell depletion at different sites after IA, SC, or IV administration of a fluorescently labeled mouse anti-CD20 B cell depleting antibody (Cy5-αCD20) in healthy mice compared to mice with collagen-induced arthritis (CIA)." [PMID:36945772]